Insights

Pertussis cases in infants under one year old are increasing in the Czech Republic, with most cases occurring in unvaccinated children within their first four months of life. This highlights the need for vaccination strategies like the "cocoon" approach and maternal immunization.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Vaccinology

Background:

  • Pertussis (whooping cough) remains a significant public health concern globally.
  • Infants under one year of age are particularly vulnerable to severe pertussis complications and mortality.
  • Understanding pertussis epidemiology in this age group is crucial for effective control strategies.

Purpose of the Study:

  • To analyze the epidemiological trends of pertussis in infants under one year of age in the Czech Republic between 1997 and 2013.
  • To identify key demographic and clinical characteristics of pertussis cases in this vulnerable population.

Main Methods:

  • Retrospective analysis of laboratory-confirmed pertussis cases in children under one year of age.
  • Data collected from the Czech Republic's communicable disease surveillance system from 1997 to 2013.
  • Evaluation of demographic data, hospitalization rates, and vaccination status.

Main Results:

  • A consistent increase in reported pertussis cases among infants was observed from 1997 to 2013, with incidence rising from 1.1 to 31.3 per 100,000 population.
  • A total of 265 cases were reported; 77% occurred within the first four months of life.
  • 79% of affected infants were unvaccinated, and 75% required hospitalization, often within the first six months of life.

Conclusions:

  • The study confirms a significant upward trend in infant pertussis in the Czech Republic.
  • The high proportion of unvaccinated infants contracting pertussis underscores the importance of vaccination, including the "cocoon" strategy (vaccinating close contacts) and potentially maternal vaccination.
  • Early-life vaccination and booster doses are critical for protecting infants against pertussis.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
149
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
74
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
16
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K